cusp for vap: evap nhsn vae surveillance definition review
DESCRIPTION
CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review. Call in information Phone #: 800.779.9891 Pass code: 4757941. CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review. Presented by: Kathleen Speck, MPH September 13, 2012 Armstrong Institute for Patient Safety and Quality. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/1.jpg)
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011
CUSP for VAP: EVAPNHSN VAE Surveillance Definition Review
Call in informationPhone #: 800.779.9891Pass code: 4757941
![Page 2: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/2.jpg)
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011
CUSP for VAP: EVAPNHSN VAE Surveillance Definition ReviewPresented by:Kathleen Speck, MPHSeptember 13, 2012 Armstrong Institute for Patient Safety and Quality
![Page 3: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/3.jpg)
Our Collaborators
– Karol G. Wicker, MHSSenior Director, Quality Policy & AdvocacyMaryland Hospital [email protected]
– Mary Catanzaro RN BSMT CIC Project Manager HAIs Hospital and Healthsystem Association of [email protected]
3
![Page 4: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/4.jpg)
Learning Objectives
• To discuss the NHSN VAE definition.• To discuss the linelist generator developed by
Dr. Michael Klompas
Armstrong Institute for Patient Safety and Quality4
![Page 5: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/5.jpg)
NHSN Surveillance 2012-2013
• Assessment must take place for all VAE tiers– VAC - Ventilator-associated Condition– IVAC - Infectious Ventilator-associated
Condition– Possible Ventilator-associated Pneumonia– Probable Ventilator-associated Pneumonia
Armstrong Institute for Patient Safety and Quality5
![Page 6: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/6.jpg)
VAC Definition Criteria8
• Patient intubated for > 2 calendar days• Baseline stability
– Baseline:• 2 calendar days immediately preceding the first
day of increased daily minimum PEEP or FiO2 requirements
– Stability:• ≥ 2 calendar days of stable or decreasing daily
minimum FiO2 or PEEP requirements
Armstrong Institute for Patient Safety and Quality6
![Page 7: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/7.jpg)
Threshold change for VAC
• Threshold rise in daily minimum:– PEEP by ≥3 cm H2O or– FiO2 by ≥20 points – sustained ≥2 days
Armstrong Institute for Patient Safety and Quality7
![Page 8: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/8.jpg)
Example - VAC
Armstrong Institute for Patient Safety and Quality8
Stable
![Page 9: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/9.jpg)
Example – no VAC
Armstrong Institute for Patient Safety and Quality9
Unstable
![Page 10: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/10.jpg)
Example – no VAC
Armstrong Institute for Patient Safety and Quality10
![Page 11: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/11.jpg)
Subsequent VAEs
• VAEs are defined as 14 days– Starts on day 1 of worsening oxygenation– New VAE cannot be reported until 14 day
period has elapsed
Armstrong Institute for Patient Safety and Quality11
![Page 12: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/12.jpg)
VAE Outcomes
• VAE = VAC, IVAC, Possible VAP and Probable VAP
• VAC = Significant respiratory deterioration after 2 or more days of stability
• IVAC = VAC + abnormal temp or WBC + ≥ 4 days of new antibiotics
• Possible VAP = IVAC + purulent sputum or positive sputum/BAL culture
• Probable VAP = IVAC + purulent sputum AND positive sputum/BAL culture
Armstrong Institute for Patient Safety and Quality12
![Page 13: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/13.jpg)
Setting Up a Linelist
Armstrong Institute for Patient Safety and Quality13
![Page 14: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/14.jpg)
Linelist Definitions
Armstrong Institute for Patient Safety and Quality14
![Page 15: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/15.jpg)
Steps to generate linelist for VAE
• Begin with “Daily Linelist”• Enter daily minimum PEEP and FiO2 for
every ventilated patient for every calendar day the patient spends any time on a ventilator
• Worksheet will automatically flag events that fulfill criteria for VAC
• If a patient is not identified as having VAC, don’t collect any further information for that patient.
Armstrong Institute for Patient Safety and Quality15
![Page 16: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/16.jpg)
Step 1 – VAC
Armstrong Institute for Patient Safety and Quality16
![Page 17: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/17.jpg)
Determination of IVAC
• Patients where VAC has already been determined
• Enter:– Tmin and Tmax– WBCmin and WBCmax – QAD – Qualifying antibiotic day
• IVAC requires 4 contiguous days of a new antibiotic starting within the 5 days starting 2 days before the onset
Armstrong Institute for Patient Safety and Quality17
![Page 18: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/18.jpg)
Step 2 - IVAC
Armstrong Institute for Patient Safety and Quality18
![Page 19: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/19.jpg)
New Antimicrobial AgentQualifying Antimicrobial Day (QAD)
• Any agent listed in the Appendix of the Device Associated Events: VAE (pages 10-19 through 10-21) that:– Is initiated on or after the third day of mechanical
ventilation AND – is started in the 5 day period defined by
• 2 days before • the day of the event• the 2 days after
AND– Was not given to the patient on either of the two days
preceding the current event
Armstrong Institute for Patient Safety and Quality19
![Page 20: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/20.jpg)
Qualifying Antibiotic Days - Timing(VAC has already been established)
Armstrong Institute for Patient Safety and Quality20
![Page 21: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/21.jpg)
Example Antibiotic Worksheet
Armstrong Institute for Patient Safety and Quality21
![Page 22: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/22.jpg)
Determination of Possible VAP or Probable VAP
• Patients where IVAC has been determined• From Sputum of BAL gram stain
– Enter• Polys – polys, neutrophils or WBC
(semiquantitative scale)• Epis – epithelial cells or squamous cells
(semiquantitative scale)• Culture – result• Quantity - threshold (10^5 for endotracheal
aspirate, 10^4 for BAL, 10^3 for protected specimen brush). Semi-quantitative equivalent also acceptable. Answer Yes or No.
Armstrong Institute for Patient Safety and Quality22
![Page 23: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/23.jpg)
Step 3 – Possible VAP or Probable VAP
Armstrong Institute for Patient Safety and Quality23
![Page 24: CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review](https://reader036.vdocument.in/reader036/viewer/2022081604/568161e5550346895dd2066b/html5/thumbnails/24.jpg)
• Questions?
Armstrong Institute for Patient Safety and Quality24